Leap therapeutics reports first quarter 2022 financial results

Cambridge, mass. , may 13, 2022 /prnewswire/ -- leap therapeutics, inc. (nasdaq:lptx), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the first quarter ended march 31, 2022.

LPTX Ratings Summary

LPTX Quant Ranking